Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
MTEX Stock Summary
In the News

Mannatech - Expected May/June Tender Offer - Price Jump
Mannatech, a multi-level-marketing company, tends to announce a large tender offer before its annual June shareholders' meeting; A new large tender offer may be launched shortly;

Mannatech: Small But Mighty Health Food Pick
Mannatech is a little-known wellness, nutrition and dietary supplement outfit with an extremely low valuation vs. peers. Pandemic forces in the economy have resulted in strong free cash flow generation, with much better final margins on sales.

7 Top-Rated Pharmaceutical Stocks To Invest in for October
It's a great time to look beyond the big name pharmaceutical stocks and look for great niche players with big futures. The post 7 Top-Rated Pharmaceutical Stocks To Invest in for October appeared first on InvestorPlace.

Mannatech Plans $1M Buyback Program
Mannatech Inc (NASDAQ: MTEX) Board of Directors has approved a share repurchase program to acquire up to $1.0 million of its outstanding common stock. The buyback program will begin on September 21, 2021, and ends on the earlier of September 21, 2022, or purchase of $1 mln common stock.

Mannatech Announces Share Repurchase Program
FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), (“Mannatech”), today announced that its Board of Directors has approved a share repurchase program to acquire up to $1.0 million of its outstanding common stock. The authorized repurchases will be made from time to time in the open market, through block trades or in privately negotiated transactions. The timing, volume and nature of share repurchases will be at the discretion of management and dependent on market cond

Mannatech Declares Second Quarter 2021 Dividend
FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend of $0.20 per share of common stock, payable on Wednesday, September 29, 2021, to shareholders of record at the close of business on Wednesday, September 15, 2021. The dividend demonstrates a commitment to rewarding shareholders and encouraging long-term investment

Mannatech Reports Second Quarter End 2021 Financial Results
FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech Reports Second Quarter End 2021 Financial Results

Mannatech Announces Final Results of Tender Offer
FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced today the final results of its cash tender offer, which expired at 12:00 midnight, New York City time, at the end of Friday, June 25, 2021, to purchase up to 211,538 shares of its outstanding common stock, par value $0.0001 per share, at a per share price of $26.00 (the "tender offer").

Mannatech Announces Preliminary Results of Tender Offer
FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced today the preliminary results of its cash tender offer, which expired at 12:00 midnight, New York City time, at the end of Friday, June 25, 2021, to purchase up to 211,538 shares of its outstanding common stock, par value $0.0001 per share, at a per share price of $26.00 (the "tender of

Mannatech Announces Results of Annual Shareholders' Meeting
FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (Nasdaq: MTEX) ("Mannatech"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at Mannatech's annual shareholder meeting (the "Meeting") held Tuesday, June 15, 2021. Mannatech's Chairman of the Board, J. Stanley Fredrick, chaired the Meeting and David Johnson, Mannatech's Chief Financial Officer, spoke to the shareholders sh
MTEX Financial details
MTEX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 68.3 | 65.97 | 67.74 | 80.28 | 71.72 | |
Net income per share | -1.53 | 1.38 | 2.8 | 4.95 | -2.35 | |
Operating cash flow per share | -0.09 | 2.06 | 2.7 | 5.41 | -1.36 | |
Free cash flow per share | -1.01 | 1.55 | 2.27 | 5.09 | -1.91 | |
Cash per share | 8.6 | 10.36 | 9.94 | 12.15 | 7.2 | |
Book value per share | 9.97 | 11.41 | 11.62 | 12.27 | 7.41 | |
Tangible book value per share | 9.89 | 11.41 | 11.62 | 12.27 | 7.41 | |
Share holders equity per share | 9.97 | 11.41 | 11.62 | 12.27 | 7.41 | |
Interest debt per share | 0.79 | 0.56 | 0.38 | 0.17 | 0.26 | |
Market cap | 47.77M | 38.47M | 41.57M | 76.26M | 34.24M | |
Enterprise value | 27.66M | 15.07M | 20.12M | 52.41M | 20.88M | |
P/E ratio | -12.29 | 11.7 | 6.64 | 7.75 | -7.63 | |
Price to sales ratio | 0.28 | 0.24 | 0.27 | 0.48 | 0.25 | |
POCF ratio | -215.18 | 7.82 | 6.89 | 7.08 | -13.18 | |
PFCF ratio | -18.66 | 10.41 | 8.18 | 7.53 | -9.35 | |
P/B Ratio | 1.89 | 1.41 | 1.6 | 3.12 | 2.42 | |
PTB ratio | 1.89 | 1.41 | 1.6 | 3.12 | 2.42 | |
EV to sales | 0.16 | 0.1 | 0.13 | 0.33 | 0.15 | |
Enterprise value over EBITDA | 14.01 | 1.77 | 3.1 | 4.87 | 17.08 | |
EV to operating cash flow | -124.58 | 3.07 | 3.34 | 4.86 | -8.03 | |
EV to free cash flow | -10.8 | 4.08 | 3.96 | 5.18 | -5.7 | |
Earnings yield | -0.08 | 0.09 | 0.15 | 0.13 | -0.13 | |
Free cash flow yield | -0.05 | 0.1 | 0.12 | 0.13 | -0.11 | |
Debt to equity | 0.07 | 0.05 | 0.03 | 0.01 | 0.03 | |
Debt to assets | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | -10.19 | -2.75 | -3.31 | -2.21 | -10.94 | |
Current ratio | 1.26 | 1.42 | 1.33 | 1.42 | 1.17 | |
Interest coverage | -0.31 | -402.06 | 54.11 | 0 | -4.6 | |
Income quality | 0.06 | 1.49 | 0.96 | 1.09 | 0.58 | |
Dividend Yield | 0.06 | 0.03 | 0.08 | 0.06 | 0.04 | |
Payout ratio | -0.79 | 0.36 | 0.54 | 0.44 | -0.34 | |
Sales general and administrative to revenue | 0.42 | 0.2 | 0.18 | 0.18 | 0.2 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 10.53 | -0.25 | -0.16 | -0.06 | 0.41 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | 0 | -0.01 | |
Capex to depreciation | -1.13 | -0.58 | -0.48 | -0.38 | -0.65 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Graham number | 18.52 | 18.79 | 27.06 | 36.95 | 19.78 | |
ROIC | 0.03 | 0.13 | 0.18 | 0.4 | -0.26 | |
Return on tangible assets | -0.06 | 0.05 | 0.1 | 0.17 | -0.09 | |
Graham Net | -3.27 | -2.06 | -4.41 | -2.36 | -6.97 | |
Working capital | 8.77M | 12.14M | 10.49M | 12.74M | 5.12M | |
Tangible asset value | 25.12M | 27.28M | 25.97M | 24.41M | 14.18M | |
Net current asset value | 5.51M | 5.38M | 3.11M | 7.63M | 1000 | |
Invested capital | 0.07 | 0.05 | 0.03 | 0.01 | 0.03 | |
Average receivables | 788.5K | 786K | 1.18M | 813K | 536.5K | |
Average payables | 6.37M | 5.13M | 4.16M | 4.38M | 4.17M | |
Average inventory | 11.1M | 11.49M | 11.49M | 12.42M | 13.37M | |
Days sales outstanding | 0.83 | 2.72 | 2.88 | 0.99 | 1.71 | |
Days payables outstanding | 71.19 | 40.79 | 49.31 | 42.42 | 48.15 | |
Days of inventory on hand | 135.74 | 117.45 | 131.86 | 128.48 | 162.58 | |
Receivables turnover | 437.17 | 134.24 | 126.81 | 369.82 | 214.05 | |
Payables turnover | 5.13 | 8.95 | 7.4 | 8.6 | 7.58 | |
Inventory turnover | 2.69 | 3.11 | 2.77 | 2.84 | 2.25 | |
ROE | -0.15 | 0.12 | 0.24 | 0.4 | -0.32 | |
Capex per share | -0.92 | -0.51 | -0.42 | -0.33 | -0.56 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 18.63 | 18.47 | 18.22 | 17.43 | 17.47 | |
Net income per share | 0.62 | -3.78 | 0.32 | -0.59 | 0.01 | |
Operating cash flow per share | -0.53 | -1.64 | 0.72 | -1.44 | 0.15 | |
Free cash flow per share | -0.72 | -1.74 | 0.67 | -1.57 | 0.05 | |
Cash per share | 7.92 | 7.41 | 7.31 | 5.01 | 4.26 | |
Book value per share | 9.76 | 7.63 | 7.4 | 6.23 | 5.74 | |
Tangible book value per share | 9.76 | 7.63 | 7.4 | 6.12 | 5.74 | |
Share holders equity per share | 9.76 | 7.63 | 7.4 | 6.23 | 5.74 | |
Interest debt per share | 3.36 | 0.24 | 0.83 | 3.8 | 0.85 | |
Market cap | 39.64M | 33.28M | 32.29M | 22.46M | 19.28M | |
Enterprise value | 30.94M | 19.91M | 20.52M | 20.18M | 12.95M | |
P/E ratio | 8.32 | -1.19 | 13.37 | -5.08 | 267.81 | |
Price to sales ratio | 1.12 | 0.97 | 0.95 | 0.69 | 0.59 | |
POCF ratio | -39.1 | -10.88 | 23.9 | -8.36 | 67.18 | |
PFCF ratio | -29 | -10.3 | 25.9 | -7.65 | 190.91 | |
P/B Ratio | 2.13 | 2.35 | 2.33 | 1.93 | 1.8 | |
PTB ratio | 2.13 | 2.35 | 2.33 | 1.93 | 1.8 | |
EV to sales | 0.87 | 0.58 | 0.6 | 0.62 | 0.4 | |
Enterprise value over EBITDA | 14.93 | -8.39 | 18.65 | -48.4 | 20.82 | |
EV to operating cash flow | -30.52 | -6.51 | 15.19 | -7.51 | 45.13 | |
EV to free cash flow | -22.64 | -6.16 | 16.45 | -6.87 | 128.23 | |
Earnings yield | 0.03 | -0.21 | 0.02 | -0.05 | 0 | |
Free cash flow yield | -0.03 | -0.1 | 0.04 | -0.13 | 0.01 | |
Debt to equity | 0.34 | 0.03 | 0.14 | 0.61 | 0.15 | |
Debt to assets | 0.12 | 0.01 | 0.04 | 0.16 | 0.04 | |
Net debt to EBITDA | -4.2 | 5.63 | -10.7 | 5.45 | -10.18 | |
Current ratio | 1.27 | 1.17 | 1.17 | 1.11 | 1.09 | |
Interest coverage | 71.42 | -85.48 | -2 | -95.4 | -10.12 | |
Income quality | -0.85 | 0.47 | 2.24 | 2.43 | 15.94 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.02 | 0 | |
Payout ratio | 0.32 | -0.05 | 0.62 | -0.34 | 0 | |
Sales general and administrative to revenue | 0.19 | 0.2 | 0.19 | 0.22 | 0.21 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.35 | 0.06 | -0.08 | 0.09 | -0.65 | |
Capex to revenue | -0.01 | -0.01 | 0 | -0.01 | -0.01 | |
Capex to depreciation | -0.49 | -0.63 | -0.27 | -0.65 | -0.41 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0 | 0 | |
Graham number | 11.72 | 25.45 | 7.33 | 9.1 | 1.12 | |
ROIC | 0.03 | -0.35 | 0.02 | -0.05 | 0 | |
Return on tangible assets | 0.02 | -0.14 | 0.01 | -0.02 | 0 | |
Graham Net | -5.61 | -7.17 | -8.06 | -8.38 | -8.31 | |
Working capital | 7.71M | 5.12M | 5.2M | 3.01M | 2.27M | |
Tangible asset value | 18.61M | 14.18M | 13.85M | 11.44M | 10.7M | |
Net current asset value | 2.55M | 1000 | -413K | -2.51M | -2.92M | |
Invested capital | 0.34 | 0.03 | 0.14 | 0.61 | 0.15 | |
Average receivables | 619K | 639.5K | 611.5K | 824.5K | 817K | |
Average payables | 4.86M | 4.47M | 5.01M | 5.74M | 4.85M | |
Average inventory | 14.57M | 14.99M | 15.02M | 15.58M | 15.59M | |
Days sales outstanding | 1.62 | 1.68 | 1.54 | 2.95 | 1.57 | |
Days payables outstanding | 55.59 | 36.91 | 68.75 | 74.85 | 52.7 | |
Days of inventory on hand | 185.08 | 124.64 | 186 | 203.52 | 208.28 | |
Receivables turnover | 55.66 | 53.56 | 58.62 | 30.55 | 57.41 | |
Payables turnover | 1.62 | 2.44 | 1.31 | 1.2 | 1.71 | |
Inventory turnover | 0.49 | 0.72 | 0.48 | 0.44 | 0.43 | |
ROE | 0.06 | -0.5 | 0.04 | -0.09 | 0 | |
Capex per share | -0.19 | -0.09 | -0.06 | -0.13 | -0.1 |
MTEX Frequently Asked Questions
What is Mannatech, Incorporated stock symbol ?
Mannatech, Incorporated is a US stock , located in Flower mound of Tx and trading under the symbol MTEX
What is Mannatech, Incorporated stock quote today ?
Mannatech, Incorporated stock price is $9.099 today.
Is Mannatech, Incorporated stock public?
Yes, Mannatech, Incorporated is a publicly traded company.